The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Yaowen Zhang, Junru Chen, Haoyang Liu, Jindong Dai, Junjie Zhao, Sha Zhu, Xingming Zhang, Jiayu Liang, Xu Hu, Jinge Zhao, Zhenhua Liu, Pengfei Shen, Guangxi Sun, Hao Zeng
Topics & Concepts
MedicineRenal cell carcinomaUrothelial carcinomaIncidence (geometry)Adverse effectCarcinomaImmune systemOncologyInternal medicineImmune checkpointImmunotherapyImmunologyCancerBladder cancerPhysicsOpticsCancer Immunotherapy and BiomarkersRenal cell carcinoma treatmentBladder and Urothelial Cancer Treatments